These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 24416534)
41. Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial. Cho BCJ; Donahoe L; Bradbury PA; Leighl N; Keshavjee S; Hope A; Pal P; Cabanero M; Czarnecka K; McRae K; Tsao MS; de Perrot M Lancet Oncol; 2021 Feb; 22(2):190-197. PubMed ID: 33450184 [TBL] [Abstract][Full Text] [Related]
42. Population based epidemiology and prognosis of mesothelioma in Leeds, UK. Chapman A; Mulrennan S; Ladd B; Muers MF Thorax; 2008 May; 63(5):435-9. PubMed ID: 18202164 [TBL] [Abstract][Full Text] [Related]
43. Dosimetric Correlates of Pulmonary Toxicity in Patients with Malignant Pleural Mesothelioma Receiving Radiation Therapy to the Intact Lungs. Thompson MR; Dumane VA; Lazarev SA; Zia Y; Rosenzweig KE Pract Radiat Oncol; 2019 May; 9(3):e331-e337. PubMed ID: 30654090 [TBL] [Abstract][Full Text] [Related]
44. Establishing locoregional control of malignant pleural mesothelioma using high-dose radiotherapy and (18) F-FDG PET/CT scan correlation. Feigen M; Lee ST; Lawford C; Churcher K; Zupan E; Scott AM; Hamilton C J Med Imaging Radiat Oncol; 2011 Jun; 55(3):320-32. PubMed ID: 21696568 [TBL] [Abstract][Full Text] [Related]
45. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
46. Extra-pleural pneumonectomy in the era of image-guided intensity-modulated radiotherapy. Trovo M; Franceschini D; Furlan C; Pietrobon F; Vagge S; Farina E; Revelant A; Visani L; Maragna V; Parisi G; Scotti V Radiol Med; 2019 Sep; 124(9):854-859. PubMed ID: 30963379 [TBL] [Abstract][Full Text] [Related]
47. PET-guided dose escalation tomotherapy in malignant pleural mesothelioma. Fodor A; Fiorino C; Dell'Oca I; Broggi S; Pasetti M; Cattaneo GM; Gianolli L; Calandrino R; Di Muzio NG Strahlenther Onkol; 2011 Nov; 187(11):736-43. PubMed ID: 22037650 [TBL] [Abstract][Full Text] [Related]
49. Preliminary results of entire pleural intensity-modulated radiotherapy in a neoadjuvant setting for resectable malignant mesothelioma. Hong JH; Lee HC; Choi KH; Moon SW; Kim KS; Hong SH; Hong JY; Kim YS Radiat Oncol J; 2019 Jun; 37(2):101-109. PubMed ID: 31266291 [TBL] [Abstract][Full Text] [Related]
50. Intensity-Modulated Radiation Therapy Improves the Target Coverage Over 3-D Planning While Meeting Lung Tolerance Doses for All Patients With Malignant Pleural Mesothelioma. Ulger S; Cetin E; Catli S; Sarac H; Kilic D; Bora H Technol Cancer Res Treat; 2017 Jun; 16(3):332-338. PubMed ID: 28462689 [TBL] [Abstract][Full Text] [Related]
51. Role of radiotherapy in adrenocortical carcinoma. Ho J; Turkbey B; Edgerly M; Alimchandani M; Quezado M; Camphausen K; Fojo T; Kaushal A Cancer J; 2013; 19(4):288-94. PubMed ID: 23867507 [TBL] [Abstract][Full Text] [Related]
52. Malignant pleural mesothelioma: Comparison of surgery-based trimodality therapy to medical therapy at two tertiary academic institutions. Larose F; Quigley N; Lacasse Y; Martel S; Lang-Lazdunski L Lung Cancer; 2021 Jun; 156():151-156. PubMed ID: 33962765 [TBL] [Abstract][Full Text] [Related]
53. [Value of tomotherapy in malignant pleural mesothelioma: first clinical results]. Giraud P; Sylvestre A; Lisbona A; Zefkili S; Bonnette P; Le Pimpec Barthes F; Michaud JL; Perigaud C; Mahé MA Rev Mal Respir; 2011 May; 28(5):609-17. PubMed ID: 21645831 [TBL] [Abstract][Full Text] [Related]
54. The treatment of malignant mesothelioma of the pleura: review of a 5-year experience, with special reference to radiotherapy. Ball DL; Cruickshank DG Am J Clin Oncol; 1990 Feb; 13(1):4-9. PubMed ID: 1689538 [TBL] [Abstract][Full Text] [Related]
55. Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience. Franceschini D; De Rose F; Cozzi S; Renna I; Franzese C; Di Brina L; Navarria P; D'Agostino GR; Mancosu P; Tomatis S; Scorsetti M Clin Lung Cancer; 2020 Jan; 21(1):86-93. PubMed ID: 31563545 [TBL] [Abstract][Full Text] [Related]
56. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Ahamad A; Stevens CW; Smythe WR; Vaporciyan AA; Komaki R; Kelly JF; Liao Z; Starkschall G; Forster KM Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):768-75. PubMed ID: 12573764 [TBL] [Abstract][Full Text] [Related]
57. Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients. Castagneto B; Zai S; Mutti L; Lazzaro A; Ridolfi R; Piccolini E; Ardizzoni A; Fumagalli L; Valsuani G; Botta M Lung Cancer; 2001; 31(2-3):303-10. PubMed ID: 11165411 [TBL] [Abstract][Full Text] [Related]
58. Radiotherapy for palliation of symptoms in incurable cancer. Hoegler D Curr Probl Cancer; 1997; 21(3):129-83. PubMed ID: 9202888 [TBL] [Abstract][Full Text] [Related]